Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy.

T Ozawa1, H Tanaka, R Nakano

  • 1Department of Neurology, Brain Research Institute, Niigata University, Japan. ozawa@bri.niigata-u.ac.jp

Journal of Neurology, Neurosurgery, and Psychiatry
|September 16, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.

Biochemical and biophysical research communications·1992
Same author

Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Journal of medicinal chemistry·1992
Same author

Substance P induces intracellular calcium increase and translocation of protein kinase C in epidermis.

The British journal of dermatology·1992
Same author

Interleukin-2 production by primary adult T cell leukemia tumor cells is macrophage dependent.

American journal of hematology·1992
Same author

Deletion of mitochondrial DNA in the endomyocardial biopsy sample from a patient with Kearns-Sayre syndrome.

European heart journal·1992
Same author

Entrainment to external Ca2+ oscillation in ionophore-treated Physarum plasmodium.

Cell structure and function·1992

Patients with multiple system atrophy (MSA) often show a nocturnal decrease in arginine vasopressin (AVP) secretion. This suggests the daily AVP secretion system may be implicated in MSA progression.

Area of Science:

  • Neuroendocrinology
  • Neurology
  • Physiology

Background:

  • A previous case study noted a nocturnal decrease in arginine vasopressin (AVP) secretion in a patient with multiple system atrophy (MSA).
  • The physiological regulation of AVP secretion involves circadian rhythms, crucial for maintaining fluid balance and blood pressure.

Purpose of the Study:

  • To investigate the prevalence of nocturnal AVP decrease in a larger cohort of MSA patients.
  • To explore the potential involvement of circadian AVP regulation in the pathophysiology of MSA.

Main Methods:

  • Plasma AVP concentrations were measured in 13 patients diagnosed with MSA.
  • Blood samples were collected at 4-hour intervals over a 24-hour period to capture diurnal variations.

Main Results:

Related Experiment Videos

  • Significant daily variations in plasma AVP levels were observed in the MSA patient group.
  • AVP concentrations were consistently lowest during nighttime hours, confirming a nocturnal decrease.

Conclusions:

  • Nocturnal reduction in AVP secretion is a common finding in patients with multiple system atrophy.
  • The circadian system regulating AVP secretion may play a role in the neurological dysfunction characteristic of MSA.